Literature DB >> 2636801

Inhibition of antiskin allograft immunity induced by infusions with photoinactivated effector T lymphocytes (PET cells).

M I Perez1, R L Edelson, L John, L Laroche, C L Berger.   

Abstract

Induction of tolerance for skin allotransplantation requires selective suppression of the host response to foreign histocompatibility antigens. This report describes a new approach which employs pre-treatment with 8-methoxypsoralen (8-MOP) and ultraviolet A light (UVA) to render the effector cells of graft rejection immunogenic for the syngeneic recipient. Eight days after BALB/c mice received CBA/j skin grafts, their splenocytes were treated with 100 ng/ml 8-MOP and 1 J/cm2 UVA prior to reinfusion into naive BALB/c recipients. Recipient mice were tested for tolerance to alloantigens in mixed leukocyte culture (MLC), cytotoxicity (CTL), delayed-type hypersensitivity assays (DTH), and challenge with a fresh CBA/j graft. Splenocytes from BALB/c recipients of photoinactivated splenocytes containing the effector cells of CBA/j alloantigen rejection proliferated poorly in MLC and generated lower cytotoxic T-cell responses to CBA/j alloantigens in comparison with sensitized and naive controls and suppressed the MLC and CTL response to alloantigen from sensitized and naive BALB/c mice. In vivo, the DTH response was specifically suppressed to the relevant alloantigen in comparison with controls. BALB/c mice treated in this fashion retained a CBA/j skin graft for up to 42 days post-transplantation without visual evidence of rejection. These results showed that reinfusion of photoinactivated effector cells resulted in an immunosuppressive host response which specifically inhibited in vitro and in vivo responses that correlate with allograft rejection and permitted prolonged retention of histoincompatible skin grafts.

Entities:  

Mesh:

Year:  1989        PMID: 2636801      PMCID: PMC2589148     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  33 in total

1.  In vivo treatment of neonatal mice with anti-I-A antibodies interferes with the development of the class I, class II, and Mls-reactive proliferating T cell subset.

Authors:  A M Kruisbeek; S Bridges; J Carmen; D L Longo; J J Mond
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

2.  Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions.

Authors:  D Sun; Y Qin; J Chluba; J T Epplen; H Wekerle
Journal:  Nature       Date:  1988-04-28       Impact factor: 49.962

Review 3.  Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex.

Authors:  J W Kappler; U Staerz; J White; P C Marrack
Journal:  Nature       Date:  1988-03-03       Impact factor: 49.962

Review 4.  Autoimmunity: physiologic and pernicious.

Authors:  I R Cohen
Journal:  Adv Intern Med       Date:  1984

Review 5.  Immunogenetic basis of acquired transplantation tolerance.

Authors:  P J Wood; J W Streilein
Journal:  Transplantation       Date:  1984-03       Impact factor: 4.939

6.  Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones.

Authors:  D J Cher; T R Mosmann
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

7.  Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells.

Authors:  R M Buller; K L Holmes; A Hügin; T N Frederickson; H C Morse
Journal:  Nature       Date:  1987 Jul 2-8       Impact factor: 49.962

8.  Downregulation of T cell responses by antibodies to the T cell receptor.

Authors:  S Webb; J Sprent
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

9.  Mls is not a single gene, allelic system. Different stimulatory Mls determinants are the products of at least two nonallelic, unlinked genes.

Authors:  R Abe; J J Ryan; R J Hodes
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

10.  Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection.

Authors:  A S Rosenberg; T Mizuochi; S O Sharrow; A Singer
Journal:  J Exp Med       Date:  1987-05-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Cutaneous T-cell lymphoma: Biologic targets for therapy.

Authors:  Jaehyuk Choi; Francine Foss
Journal:  Curr Hematol Malig Rep       Date:  2007-10       Impact factor: 3.952

2.  Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells.

Authors:  Erin Gatza; Clare E Rogers; Shawn G Clouthier; Kathleen P Lowler; Isao Tawara; Chen Liu; Pavan Reddy; James L M Ferrara
Journal:  Blood       Date:  2008-04-14       Impact factor: 22.113

Review 3.  Transplant Tolerance Induction: Insights From the Liver.

Authors:  Helong Dai; Yawen Zheng; Angus W Thomson; Natasha M Rogers
Journal:  Front Immunol       Date:  2020-06-05       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.